Lynwood Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Lynwood Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-31,454	Closed	-$324K	–	161
2022 Q4	$324K	Hold	31,454	–	–	0.39%	64
2022 Q3	$317K	Hold	31,454	–	–	0.35%	72
2022 Q2	$315K	Hold	31,454	–	–	0.35%	66
2022 Q1	$315K	Buy	+31,454	New	+$312K	0.34%	67

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Lynwood Capital Management's IQMD Position: Q1 2023 in Review

Lynwood Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 31,454 shares — an estimated $324K sold.

Lynwood Capital Management first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $324K in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Lynwood Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Lynwood Capital Management sold 31,454 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $324K.
Lynwood Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Lynwood Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $324K in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Lynwood Capital Management's 13F filing for Q1 2023, filed 12 May 2023.